OXON is a European based global full-service CRO specialising in single and multi-country data collection, secondary data and hybrid observational studies, pragmatic trials and meta-analyses for safety, market access and drug development.
We combine high quality clinical, epidemiological, statistical and qualitative science and operational experience, with technology using our proprietary and validated EDC platform built specifically for observational studies.
At OXON we have led initiatives at ENCePP, presented on risk minimisation at the EMA and our staff are authors of observational studies in high impact journals (e.g. x7 Lancets). We have strong academic links with the Medical Statistics Unit at the London School of Hygiene & Tropical Medicine, and leading pharmaco-epidemiologists in Europe.
We are a preferred provider for several top-20 pharma companies for real-world studies.
- Ask us to present our projects on EU PASS studies, of which we are presenting two posters at this virtual ICPE conference.
- Ask us to present our COVID-19 'spin off' projects for industry. We already have participation from one top-10 pharma.